Beyond Air (XAIR) Fiscal Q1 2027 Earnings Call: FDA Catalyst, $8M 2026 OutlookTradingKey·13 hours agoXAIR-8.74%
Beyond Air Q1 FY27 net loss widens to $8.15 million; revenue flat at $1.77 millionPUBT·1 day ago, 03:34 PMXAIR-8.74%
XAIR: Flat revenue, improved margins, and strong outlook hinge on FDA approval and new product launchQuartr·1 day ago, 06:18 AMXAIR-8.74%
The 'Others' Bucket of Wall Street: Who's Faking It and Who's Actually Making MoneyGlobal Report·Aug 4 at 04:31 AMXAIR-8.74%ADGM+0.32%
Top Biotech Gainers: UPC Cuts Loss, CPIX Gains Ahead Of Q2 Results, AUTL Builds Commercial Momentumrttnews·Aug 3 at 09:33 PMXAIR-8.74%CAMP+20.89%
Beyond Air CFO Daniel J. Moorhead acquires 4,340 common shares for $24,998.4PUBT·Jul 31 at 05:21 PMXAIR-8.74%
Beyond Air prices $5.51 Series A and Series B warrants in $30.1 million private placementPUBT·Jul 30 at 06:12 AMXAIR-8.74%
